Error: Could not add to watchlist. X

Alnylam Pharmaceuticals Inc

+ Watchlist
ALNY:US
NASDAQ GS
118.60
USD
0.76
0.64%
As of 15:55:43 ET on 07/06/2015.
Open
116.80
Day Range
114.73 - 120.68
Volume
594,712
Previous Close
117.84
52Wk Range
51.93 - 140.00
1 Yr Return
80.45%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.11
Market Cap (b USD)
9.827
Shares Outstanding (m)
84.283
Price/Sales (TTM)
152.44
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
ADDRESS
300 Third Steet
Cambridge, MA 02142
United States
PHONE
1-617-551-8200
  • John M Maraganore
    Chief Executive Officer
  • Barry E Greene
    President/COO
  • David-Alexandre Gros
    Senior VP/Chief Business Ofcr
  • Akshay K Vaishnaw
    Exec VP:Research & Dev
  • Laurie Bartlett Keating
    Senior VP/Secretary/Gen Cnsl
Show More